Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.

ABSTRACT:

SUBMITTER: Karagiannis T 

PROVIDER: S-EPMC4785858 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature